144//SEC Filing
Werewolf Therapeutics, Inc. 144
Accession 0001628280-25-059020
CIK 0001691428other
Filed
Dec 28, 7:00 PM ET
Accepted
Dec 29, 4:47 PM ET
Size
336.7 KB
Accession
0001628280-25-059020
Documents
Issuer
UBS Oncology Impact Fund L.P.
CIK 0001691428
Entity typeother
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001691428
Filing Metadata
- Form type
- 144
- Filed
- Dec 28, 7:00 PM ET
- Accepted
- Dec 29, 4:47 PM ET
- Size
- 336.7 KB